MGH researcher develops promising Alzheimer's drug

Seventeen years after a conversation on the beach, Alzheimer's researchers have co-developed a potential drug, and Tanzi hopes to begin Phase 1 clinical trials on it in the upcoming year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.